Company research / ULBI

Ultralife Corp (ULBI)

SEC name ULTRALIFE CORP · CIK 0000875657 · Nasdaq · Miscellaneous Electrical Machinery, Equipment & Supplies

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Ultralife Corp reported revenue of $191.16M. Revenue grew 16.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $187.24M.

Key ratios (year ended 2025-12-31)

24.1%
Gross margin
-3.1%
Operating margin
-3.1%
Net margin
-4.5%
Return on year-end equity
16.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-08-07

Headquarters locality: Newark · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$187.24M$191.16M$164.46M$158.64M$131.84M$98.27M$107.71M$106.80M$87.19M$85.53M$82.46M
Cost of Revenue$141.59M$145.14M$122.14M$119.44M$102.44M$73.62M$78.55M$75.63M$61.61M$59.30M$57.35M
Gross Profit$45.65M$46.02M$42.31M$39.20M$29.40M$24.64M$29.16M$31.16M$25.58M$26.23M$25.11M
R&D Expense$11.86M$10.40M$8.27M$7.53M$7.08M$6.83M$5.95M$6.80M$4.51M$4.74M$5.95M
Operating Income-$8.34M-$5.90M$9.96M$9.47M$129.0K$35.0K$5.70M$7.37M$6.55M$6.48M$3.76M
Depreciation & Amortizationn/an/an/a$3.91M$4.46M$3.54M$2.94M$2.75M$2.37M$2.43M$2.73M
EBITDAn/an/an/a$13.39M$4.59M$3.57M$8.64M$10.11M$8.92M$8.90M$6.49M
Net Income-$6.55M-$5.90M$6.31M$7.20M-$119.0K-$234.0K$5.23M$5.21M$24.93M$7.65M$3.51M
EPS (Diluted)n/a-$35.00$38.00$0.44$0.05$0.05$0.33$32.00$1.53$0.48$0.23
Total Assets$216.16M$216.91M$220.45M$178.28M$168.43M$159.54M$137.70M$144.56M$120.85M$97.19M$84.74M
Total Liabilities$83.56M$86.78M$86.26M$52.85M$52.03M$41.80M$20.78M$34.81M$16.39M$18.14M$16.88M
Long-Term Debtn/an/a$55.00M$25.75M$21.50Mn/an/an/an/an/an/a
Shareholders' Equity$132.60M$130.13M$134.19M$125.43M$116.40M$117.74M$116.92M$109.75M$104.46M$79.05M$67.86M
Cash & Equivalentsn/a$9.35M$6.85M$10.20M$5.63M$8.33M$10.56M$7.13M$25.58M$18.24Mn/a
Operating Cash Flow$5.13M$10.99M$16.64M$1.93M-$1.26M$4.33M$21.72M-$2.97M$10.89M$7.27M$7.65M
Capital Expenditures$3.10M$3.87M$1.93M$2.55M$1.68M$2.81M$3.10M$6.28M$4.18M$1.39M$1.22M
Free Cash Flow$2.03M$7.12M$14.70M-$623.0K-$2.94M$1.51M$18.62M-$9.25M$6.70M$5.88M$6.43M
Share Repurchasesn/an/an/an/an/an/a$0$1.96M$742.0Kn/a$607.0K
Shares Outstanding16.66M16.66Mn/a16.35M16.35M16.09M15.96M15.87M15.92M15.65M15.31M
Weighted Average Diluted Sharesn/a16.64Mn/a16.23M16.12M16.04M16.10M16.18M16.35M15.86M15.40M
EPS (Basic)n/a-$35.00$38.00$0.44$0.05$0.05$0.33$33.00$1.57$0.49$0.23

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView